Literature DB >> 21356378

M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Stefan Prokop1, Frank L Heppner, Hans H Goebel, Werner Stenzel.   

Abstract

The etiopathogenesis of sarcoidosis, a systemic granulomatous disease, still remains obscure. A multitude of organs have been described to be affected in systemic sarcoidosis. Skeletal muscles may also be affected, leading to myalgia and weakness. A workup of the specific immune response with emphasis on the macrophage response is provided herein. Affected muscle tissue from seven patients with systemic sarcoidosis was analyzed and compared with that from seven patients with other myopathies containing macrophagocytic infiltration. Monocytes/macrophages and giant cells in granulomas of muscle tissue from patients with sarcoidosis show a status of alternative activation (M2) based on their expression of CD206, CD301, arginase-1, and suppressor of cytokine signaling-1 as a consequence of a functionally type 2 helper T cell (Th2)-biased cytokine profile. Significant fibrosis and up-regulation of CCL18 were associated with the M2 phenotype of macrophages. Conversely, up-regulated Th1 cytokines did not result in significant classical activation of macrophages (M1), with poor inducible nitric oxide synthase and cyclooxygenase-2 production. Giant cell formation was further associated with up-regulated expression of DNAX-activating protein of 12 kDa (DAP12; gene symbol TYROBP). Functionally, alternative activation of macrophages on the basis of a Th2-biased immune response may induce clinical symptoms and chronic evolution of neuromuscular sarcoidosis. This is the first characterization of Th2-mediated immune mechanisms in neuromuscular sarcoidosis suggesting that a specific macrophage activation status leading to myofibrosis may be a key event in the pathogenesis of this disease.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356378      PMCID: PMC3069905          DOI: 10.1016/j.ajpath.2010.11.065

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Alternative versus classical activation of macrophages.

Authors:  S Goerdt; O Politz; K Schledzewski; R Birk; A Gratchev; P Guillot; N Hakiy; C D Klemke; E Dippel; V Kodelja; C E Orfanos
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

2.  American Thoracic Society issues consensus statement on sarcoidosis.

Authors:  S S Morey
Journal:  Am Fam Physician       Date:  2000-01-15       Impact factor: 3.292

Review 3.  Immune mechanisms in interstitial lung diseases.

Authors:  G Semenzato; F Adami; N Maschio; C Agostini
Journal:  Allergy       Date:  2000-12       Impact factor: 13.146

4.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

5.  Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

Authors:  M Möllers; S P Aries; D Drömann; B Mascher; J Braun; K Dalhoff
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

Review 6.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

Review 7.  New pathogenetic insights into the sarcoid granuloma.

Authors:  C Agostini; F Adami; G Semenzato
Journal:  Curr Opin Rheumatol       Date:  2000-01       Impact factor: 5.006

8.  Sarcoidosis and hepatitis C: clinical description of 11 cases.

Authors:  Pierre Faurie; Christiane Broussolle; Fabien Zoulim; Christian Trepo; Pascal Sève
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 2.566

9.  Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40.

Authors:  Yuki Kinjo; Kazuyoshi Kawakami; Kaori Uezu; Satomi Yara; Kazuya Miyagi; Yoshinobu Koguchi; Tomoaki Hoshino; Masaki Okamoto; Yusuke Kawase; Koichi Yokota; Kohichiro Yoshino; Kiyoshi Takeda; Shizuo Akira; Atsushi Saito
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

10.  Essential role of DAP12 signaling in macrophage programming into a fusion-competent state.

Authors:  Laura Helming; Elena Tomasello; Themis R Kyriakides; Fernando O Martinez; Toshiyuki Takai; Siamon Gordon; Eric Vivier
Journal:  Sci Signal       Date:  2008-10-28       Impact factor: 8.192

View more
  39 in total

1.  Increased Adipocyte Area in Injured Muscle With Aging and Impaired Remodeling in Female Mice.

Authors:  Caitlin M Fearing; David W Melton; Xiufen Lei; Heather Hancock; Hanzhou Wang; Zaheer U Sarwar; Laurel Porter; Matthew McHale; Linda M McManus; Paula K Shireman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-13       Impact factor: 6.053

2.  Proceedings of the Americas Association of Sarcoidosis and Other Granulomatous Diseases (AASOG) 2017 annual meeting.

Authors:  Richard C Bernstein; Lisa A Maier; Elliott Crouser
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 3.  Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.

Authors:  Xiao-Lei Huang; Yu-Jie Wang; Jun-Wei Yan; Ya-Nan Wan; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflamm Res       Date:  2015-03-01       Impact factor: 4.575

Review 4.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 5.  It's a cell-eat-cell world: autophagy and phagocytosis.

Authors:  Elizabeth A Oczypok; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2013-01-29       Impact factor: 4.307

6.  Description of the immune microenvironment of chondrosarcoma and contribution to progression.

Authors:  François A Simard; Iseulys Richert; Alexandra Vandermoeten; Anne-Valérie Decouvelaere; Jean-Philippe Michot; Christophe Caux; Jean-Yves Blay; Aurélie Dutour
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

7.  IL-13-regulated Macrophage Polarization during Granuloma Formation in an In Vitro Human Sarcoidosis Model.

Authors:  Landon W Locke; Elliott D Crouser; Peter White; Mark W Julian; Evelyn Guirado Caceres; Audrey C Papp; Van T Le; Wolfgang Sadee; Larry S Schlesinger
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

8.  Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues.

Authors:  Peter Nollau; Gerrit Wolters-Eisfeld; Naghmeh Mortezai; Anna-Katharina Kurze; Birgit Klampe; Annegret Debus; Maximilian Bockhorn; Axel Niendorf; Christoph Wagener
Journal:  J Histochem Cytochem       Date:  2012-12-28       Impact factor: 2.479

9.  Altered macrophage phenotype transition impairs skeletal muscle regeneration.

Authors:  Hanzhou Wang; David W Melton; Laurel Porter; Zaheer U Sarwar; Linda M McManus; Paula K Shireman
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

Review 10.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.